Table of Contents

The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Myeloid Leukemia in Adults

The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Myelogenous Leukemia in Adults: An Evidence-Based Review

Denise M. Oliansky, Frederick Appelbaum, Peter A. Cassileth, Armand Keating, Jamie Kerr, Yago Nieto, Susan Stewart, Richard M. Stone, Martin S. Tallman, Philip L. McCarthy, Jr., Theresa Hahn

Hematopoietic Stem Cell Transplantation after Reduced Intensity Conditioning in Acute Myelogenous Leukemia Patients Older Than 40 Years

Cynthia Huisman, Ellen Meijer, Eefke J. Petersen, Henk M. Lokhorst, Leo F. Verdonck

HLA-Identical Sibling Allogeneic Transplants versus Chemotherapy in Acute Myelogenous Leukemia with t(8;21) in First Complete Remission: Collaborative Study between the German AML Intergroup and CIBMTR

Richard F. Schlenk, Marcelo C. Pasquini, Waleska S. Pérez, Mei-Jie Zhang, Jürgen Krauter, Joseph H. Antin, Asad Bashey, Brian J. Bolwell, Thomas Büchner, Jean-Yves Cahn, Mitchell S. Cairo, Edward A. Copelan, Corey S. Cutler, Hartmut Döhner, Robert Peter Gale, Osman Ilhan, Hillard M. Lazarus, Jane L. Liesveld, Mark R. Litzow, David I. Marks, Richard T. Maziarz, Philip L. McCarthy, Stephen D. Nimer, Jorge Sierra, Martin S.Tallman, Daniel J. Weisdorf, Mary M. Horowitz, Arnold Ganser, on behalf of the CIBMTR Acute Leukemia Working Committee

Costs of Allogeneic Hematopoietic Cell Transplantation with High-Dose Regimens

Akiko M. Saito, Corey Cutler, David Zahrieh, Robert J. Soiffer, Vincent T. Ho, Edwin P. Alyea, John Koreth, Joseph H. Antin, and Stephanie J. Lee

Elevated Numbers of Immature/Transitional CD21− B Lymphocytes and Deficiency of Memory CD27+ B Cells Identify Patients with Active Chronic Graft-versus-Host Disease

Hildegard T. Greinix, David Pohlreich, Michal Kouba, Ulrike Körmöczi, Imke Lohmann, Karin Feldmann, Christoph Zielinski, and Winfried F. Pickl

High Busulfan Exposure Is Associated with Worse Outcomes in a Daily i.v. Busulfan and Fludarabine Allogeneic Transplant Regimen

Michelle Geddes, S. Bill Kangarloo, Farrukh Naveed, Diana Quinlan, M. Ahsan Chaudhry, Douglas Stewart, M. Lynn Savoie, Nizar J. Bahlis, Christopher Brown, Jan Storek, Borje S. Andersson, James A. Russell

Cardiac Chamber Hypertrophy following Hematopoietic Stem Cell Transplantation for Primary Immunodeficiency

Sean R. Bulley, Lee Benson, Eyal Grunebaum, Chaim M. Roifman

Allogeneic Transplants in Follicular Lymphoma: Higher Risk of Disease Progression after Reduced-Intensity Compared to Myeloablative Conditioning

Parameswaran Hari, Jeanette Carreras, Mei-Jie Zhang, Robert Peter Gale, Brian J. Bolwell, Christopher N. Bredeson, Linda J. Burns, Mitchell S. Cairo, César O. Freytes, Steven C. Goldstein,Gregory A. Hale, David J. Inwards, Charles F. LeMaistre, Dipnarine Maharaj, David I. Marks, Harry C. Schouten, Shimon Slavin, Julie M. Vose, Hillard M. Lazarus, Koen van Besien

Reduced-Intensity Conditioning followed by Allogeneic Hematopoietic Cell Transplantation for Adult Patients with Myelodysplastic Syndrome and Myeloproliferative Disorders

Ginna G. Laport, Brenda M. Sandmaier, Barry E. Storer, Bart L. Scott, Monic J. Stuart, Thoralf Lange, Michael B. Maris, Edward D. Agura, Thomas R. Chauncey, Ruby M. Wong, Stephen J. Forman, Finn B. Petersen, James C. Wade, Elliot Epner, Benedetto Bruno, Wolfgang A. Bethge, Peter T. Curtin, David G. Maloney, Karl G. Blume, Rainer F. Storb

Sirolimus Associated Pneumonitis after Nonmyeloablative Peripheral Blood Stem Cell Transplant for Sickle Cell Disease

Matthew M. Hsieh, M. Beth Link, John F. Tisdale